Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-04-27
1997-09-02
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540214, C07D41712, A61K 3154
Patent
active
056631642
ABSTRACT:
Novel 1-dethia-2-thia-cephalosporanic acid derivatives of the formula ##STR1## wherein R is selected from the group consisting of ##STR2## Ra is an organic radical, R.sub.i and R.sub.j are individually selected from the group consisting of hydrogen, aliphatic, aromatic and heterocycle or taken together with the nitrogen atom to which they are attached form an optionally substituted cycle or R.sub.b NH--, R.sub.b is optionally substituted carbocyclic or heterocyclic aryl, R.sub.1 and --COM are as defined in the specification, R.sub.4 is hydrogen or methoxy, n.sub.2 is 0, 1 or 2 and their non-toxic, pharmaceutically acceptable acid addition salts in racemic or optically active form having antibiotic activity and their preparation and novel intermediates.
REFERENCES:
patent: 4072674 (1978-02-01), Gleason
patent: 4166816 (1979-09-01), Gleason
patent: 4908359 (1990-03-01), Costerousse
patent: 5385897 (1995-01-01), Teutsch
Aszodi Jozsef
Bonnet Alain
Costerousse Germain
d'Ambrieres Solange Gouin
Teutsch Jean-Georges
Grumbling Matthew V.
Roussel Uclaf
Wong King Lit
LandOfFree
1-dethia-2-thia-cephalosporanic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-dethia-2-thia-cephalosporanic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-dethia-2-thia-cephalosporanic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308329